Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

GPS collars 'can monitor response to treatment'
Collie Max with GPS collar
Edinburgh vets hope to use GPS collars in future to learn more about how physical activity affects disease.

Vets study the effect of medication on dogs with osteoathritis

GPS technology could be used by vets to monitor the effects of certain medications. In a recent study, Edinburgh vets used GPS collars to determine the effects of painkillers in dogs with osteoarthritis.

Using the technology, vets from the Royal (Dick) School of Veterinary Studies were able to compare the movements of healthy dogs, to those of dogs with osteoarthritis.

According to their findings, published in the journal PLOS One, dogs treated with the anti-inflammatory painkiller Carprofen could run in nearly the same way as healthy dogs.

Lead researcher Dr Dylan Clements, said: "GPS collars have given us an insight into the levels of physical performance dogs exhibit during their normal daily activities, and show us how much we can alter a dog’s performance by keeping them on or off a lead, or playing with them.
 
"We found that they were a sensitive way for us to measure how well dogs recover from a disease that affects activity, such as osteoarthritis. We hope to be able to use the collars to understand more about how activity might contribute to or help prevent diseases in the future."

The collars allowed vets to monitor how quickly the dogs moved and changed speed, as well as how far they travelled during their normal exercise regime.

According to data collected from the collars, the dogs with osteoarthritis were able to run as quickly as healthy dogs, but their condition significantly affected their ability to speed up and slow down.

When they were treated with Carprofen, however, their performance improved to a level comparable to that of the healthy dogs for most of the measures taken during the study.

To view the research, visit: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117094
 

Image © Dr Stephen Ellwood, Royal (Dick) School of Veterinary Studies

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.